Episode 138: COVID-19 & MS In Minority Populations with Dr. Mitzi Joi Williams
RealTalk MS20 Huhti 2020

Episode 138: COVID-19 & MS In Minority Populations with Dr. Mitzi Joi Williams

This week, and for the foreseeable future, we're committed to sharing the most updated and reliable information on COVID-19 and MS.

Returning as my guest on the podcast is Dr. Mitzi Joi Williams. Dr. Williams is a Board-Certified Neurologist and Fellowship trained Multiple Sclerosis Specialist who is passionate about educating and empowering people affected by MS to understand the disease process and the goals of treatment. She is a sought-after consultant, speaker, researcher, and author with expertise in understanding MS in underserved and ethnic minority populations.

Dr. Williams is giving us our weekly update on what we're learning about COVID-19 & MS. We're talking about COVID-19 and starting, stopping, or pausing disease-modifying therapies. And we're taking a closer at how COVID-19 is impacting minority populations and how MS itself impacts minority populations differently.

We'll tell you everything you need to know about COVID-19 tests, COVID-19 antibody tests, and those shady COVID-19 at-home test kits.

We'll also tell you about how some MS clinical trials are being paused, and what that means when it comes to the availability of new disease-modifying therapies.

And we'll tell you about a study that shows that ethnicity is not a factor in predicting cognitive impairment in early MS. But the study may have inadvertently highlighted an unfortunate reality in our society.

We have a lot to talk about! Are you ready for RealTalk MS??!

The Best Email Ever :35

Everything You Need to Know About COVID-19 Tests 3:36

Atara Biotherapeutics Pauses ATA 188 Clinical Trial for PPMS and SPMS 8:34

Study Shows Cognitive Impairment in Early MS Not Linked to Ethnicity 11:22

My Interview with Dr. Mitzi Joi Williams 15:50

Share this episode 31:11

Donate to Walk-MS 21:43

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/138

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us on the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating & Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

Race, Ethnicity, and Cognition in Persons Newly Diagnosed with Multiple Sclerosis

The RealTalk MS Facebook Group

Jon's WALK-MS Fundraising Page

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating & Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 138
Hosted By: Jon Strum
Guests: Dr. Mitzi Joi Williams

Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Ocrevus, Coronavirus, COVID19, RealTalkMS

Privacy Policy

Jaksot(505)

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Welcome back to the third and final part of our coverage of the 2026 ACTRIMS Forum. This week's episode bridges the gap between groundbreaking clinical research and the nuanced reality of living with ...

23 Helmi 35min

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Helmi 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Helmi 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Helmi 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Tammi 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Tammi 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Tammi 29min

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS ...

5 Tammi 34min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
tiedenaiset-podcast
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
puhu-muru
rss-pitaisko-erota
katilon-kahvitunti
meditaatiot-suomeksi
rss-pt-paahtio
rss-uplevel-by-sonja-hannus
rss-narsisti
rss-rakas-mielenterveyteni
audio-sport-juoksu
junnut-pelissa
rss-ehjaksi
rss-mighty-finland-podcast
rss-kuumilla-aalloilla
selviytyjat-tarinoita-elamasta
rss-duodecim-lehti